Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN

Pharmacology

Primary Target
interleukin 1 receptor associated kinase 4

Indications

Mesh Heading Maximum Phase Reference
Arthritis; Arthritis, Rheumatoid Phase 2 ClinicalTrials
CONTENTS